These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33401933)

  • 1. MTORC1-Regulated Metabolism Controlled by TSC2 Limits Cardiac Reperfusion Injury.
    Oeing CU; Jun S; Mishra S; Dunkerly-Eyring BL; Chen A; Grajeda MI; Tahir UA; Gerszten RE; Paolocci N; Ranek MJ; Kass DA
    Circ Res; 2021 Mar; 128(5):639-651. PubMed ID: 33401933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.
    Ranek MJ; Kokkonen-Simon KM; Chen A; Dunkerly-Eyring BL; Vera MP; Oeing CU; Patel CH; Nakamura T; Zhu G; Bedja D; Sasaki M; Holewinski RJ; Van Eyk JE; Powell JD; Lee DI; Kass DA
    Nature; 2019 Feb; 566(7743):264-269. PubMed ID: 30700906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKG1α Cysteine-42 Redox State Controls mTORC1 Activation in Pathological Cardiac Hypertrophy.
    Oeing CU; Nakamura T; Pan S; Mishra S; Dunkerly-Eyring BL; Kokkonen-Simon KM; Lin BL; Chen A; Zhu G; Bedja D; Lee DI; Kass DA; Ranek MJ
    Circ Res; 2020 Jul; 127(4):522-533. PubMed ID: 32393148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic remodeling precedes mTORC1-mediated cardiac hypertrophy.
    Davogustto GE; Salazar RL; Vasquez HG; Karlstaedt A; Dillon WP; Guthrie PH; Martin JR; Vitrac H; De La Guardia G; Vela D; Ribas-Latre A; Baumgartner C; Eckel-Mahan K; Taegtmeyer H
    J Mol Cell Cardiol; 2021 Sep; 158():115-127. PubMed ID: 34081952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapy.
    Patel CH; Dong Y; Koleini N; Wang X; Dunkerly-Eyring BL; Wen J; Ranek MJ; Bartle LM; Henderson DB; Sagert J; Kass DA; Powell JD
    JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37788104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells.
    Wang J; Filippakis H; Hougard T; Du H; Ye C; Liu HJ; Zhang L; Hindi K; Bagwe S; Nijmeh J; Asara JM; Shi W; El-Chemaly S; Henske EP; Lam HC
    Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34544857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-ischaemic mitochondrial substrate constraint by inhibition of malate-aspartate shuttle preserves mitochondrial function after ischaemia-reperfusion.
    Jespersen NR; Yokota T; Støttrup NB; Bergdahl A; Paelestik KB; Povlsen JA; Dela F; Bøtker HE
    J Physiol; 2017 Jun; 595(12):3765-3780. PubMed ID: 28093764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of TSC2 by PKC-δ reveals a novel signaling pathway that couples protein synthesis to mTORC1 activity.
    Zhan J; Chitta RK; Harwood FC; Grosveld GC
    Mol Cell Biochem; 2019 Jun; 456(1-2):123-134. PubMed ID: 30684133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the malate-aspartate shuttle by pre-ischaemic aminooxyacetate loading of the heart induces cardioprotection.
    Støttrup NB; Løfgren B; Birkler RD; Nielsen JM; Wang L; Caldarone CA; Kristiansen SB; Contractor H; Johannsen M; Bøtker HE; Nielsen TT
    Cardiovasc Res; 2010 Nov; 88(2):257-66. PubMed ID: 20562422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of 6-phosphofructo-2-kinase (PFKFB3) by hyperactivated mammalian target of rapamycin complex 1 is critical for tumor growth in tuberous sclerosis complex.
    Wang Y; Tang S; Wu Y; Wan X; Zhou M; Li H; Zha X
    IUBMB Life; 2020 May; 72(5):965-977. PubMed ID: 31958214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single serine on TSC2 exerts biased control over mTORC1 activation mediated by ERK1/2 but not Akt.
    Dunkerly-Eyring BL; Pan S; Pinilla-Vera M; McKoy D; Mishra S; Grajeda Martinez MI; Oeing CU; Ranek MJ; Kass DA
    Life Sci Alliance; 2022 Jun; 5(6):. PubMed ID: 35288456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotection via preserved mitochondrial structure and function in the mPer2-mutant mouse myocardium.
    Virag JA; Anderson EJ; Kent SD; Blanton HD; Johnson TL; Moukdar F; DeAntonio JH; Thayne K; Ding JM; Lust RM
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H477-83. PubMed ID: 23771689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine controls insulin/mammalian target of rapamycin complex 1 activity by modulating tuberous sclerosis complex 2 stability.
    Gen S; Matsumoto Y; Suzuki T; Inoue J; Yamamoto Y
    Biochem Biophys Res Commun; 2021 Feb; 541():84-89. PubMed ID: 33482580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of C/EBPβ and TSC2 by an HDAC inhibitor CG200745 protects heart from DOCA-induced hypertrophy.
    Lee E; Lee HA; Kim M; Do GY; Cho HM; Kim GJ; Jung H; Song JH; Cho JM; Kim I
    Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):226-236. PubMed ID: 30099761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the
    Rossetti CL; Alves BL; Peçanha FLM; Franco AT; Nosé V; Carneiro EM; Lew J; Bernal-Mizrachi E; Werneck-de-Castro JP
    Thyroid; 2024 Aug; 34(8):1047-1057. PubMed ID: 38661550
    [No Abstract]   [Full Text] [Related]  

  • 16. mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy.
    Taneike M; Nishida K; Omiya S; Zarrinpashneh E; Misaka T; Kitazume-Taneike R; Austin R; Takaoka M; Yamaguchi O; Gambello MJ; Shah AM; Otsu K
    PLoS One; 2016; 11(3):e0152628. PubMed ID: 27023784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSC2 regulates microRNA biogenesis via mTORC1 and GSK3β.
    Ogórek B; Lam HC; Khabibullin D; Liu HJ; Nijmeh J; Triboulet R; Kwiatkowski DJ; Gregory RI; Henske EP
    Hum Mol Genet; 2018 May; 27(9):1654-1663. PubMed ID: 29509898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC6-G3BP2 promotes lysosomal-TSC2 and suppresses mTORC1 under ETV4 targeting-induced low-lactate stress in non-small cell lung cancer.
    Liu B; Zhang J; Meng X; Xie SM; Liu F; Chen H; Yao D; Li M; Guo M; Shen H; Zhang X; Xing L
    Oncogene; 2023 Apr; 42(15):1181-1195. PubMed ID: 36823378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced cardiac CapZ protein protects hearts against acute ischemia-reperfusion injury and enhances preconditioning.
    Yang FH; Pyle WG
    J Mol Cell Cardiol; 2012 Mar; 52(3):761-72. PubMed ID: 22155006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic profiling of the heart during acute ischemic preconditioning reveals a role for SIRT1 in rapid cardioprotective metabolic adaptation.
    Nadtochiy SM; Urciuoli W; Zhang J; Schafer X; Munger J; Brookes PS
    J Mol Cell Cardiol; 2015 Nov; 88():64-72. PubMed ID: 26388263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.